Microarray News

Thermo Fisher Scientific Launches Axiom Microbiome Array for Research

Thermo Fisher Scientific, the world leader in serving science, recently launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of archaea, bacteria, fungi, protozoa and viruses in human and non-human samples. Developed in collaboration with the Lawrence Livermore National Laboratory (LLNL), the array is designed to increase the understanding of microorganisms, while ...

Feb. 5, 2018

By Thermo Fisher Scientific, LIMS & Laboratory Software
Agilent Technologies Launches Updated Gene Expression Microarrays for Human, Mouse and Rat Models

Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide up-to-date tools for researchers to investigate expression patterns on a highly accessible platform. Agilent developed the updates to its flagship ...

Jun. 8, 2015

By Agilent Technologies, Inc.
Agilent Technologies Microarray Scanner Approved for In Vitro Diagnostics in China

Agilent Technologies Inc. (NYSE: A) today announced that the China Food and Drug Administration has approved the company's SureScan Dx microarray scanner as a medical device for in vitro diagnostic use. "Bringing microarray scanning technology to clinical-quality standards is an important milestone in moving the advancement of genome-wide chromosome analysis to the clinic," said Dr. Richard ...

Jan. 27, 2015

By Agilent Technologies, Inc.
Agilent Technologies Introduces Microarray for Rapid Screening of Aneuploidy in Single Cells from Embryos

Agilent Technologies Inc. (NYSE: A) today introduced the GenetiSure Pre-Screen Kit, a high-throughput oligonucleotide microarray for screening aneuploidy and other genomic aberrations in the 5- to 10-Mb range from single cells in three- and five-day embryos. Agilent's kit allows for a turnaround time of less than eight hours from DNA extraction to data analysis-an industry first. The kit ...

Jan. 12, 2015

By Agilent Technologies, Inc.
Agilent Technologies Introduces miRNA Microarrays Featuring Latest miRBase 21 Content

Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint miRNA Microarrays to include targets from the latest public miRNA miRBase database. The database, miRBase 21, contains 28,645 entries, including more than 15 percent in content added from miRBase 20. Agilent SurePrint miRNA Microarrays feature innovative labeling and hairpin probe designs to provide exceptional sequence ...

Oct. 21, 2014

By Agilent Technologies, Inc.
FLUOROFEST 2014 to be held in Raleigh/Durham, in conjuction with the Carolina Biophysics Symposium

FluoroFest, an annual international series of free workshops dedicated to Fluorescence techniques, will be held in the Raleigh/Durham area, at the Hilton Hotel near Duke University of North Carolina, in conjunction with the Carolina Biophysics Symposium. It is open to anyone interested in the exciting field of fluorescence. FluoroFest is a series of global workshops designed to give both ...

Oct. 15, 2014

By HORIBA Europe GmbH
FLUOROFEST 2014 to be held in Raleigh/Durham, in conjuction with the Carolina Biophysics Symposium

FluoroFest, an annual international series of free workshops dedicated to Fluorescence techniques, will be held in the Raleigh/Durham area, at the Hilton Hotel near Duke University of North Carolina, in conjunction with the Carolina Biophysics Symposium. It is open to anyone interested in the exciting field of fluorescence. FluoroFest is a series of global workshops designed to give both ...

Oct. 15, 2014

By HORIBA Europe GmbH
Agilent Technologies Introduces New Exome Optimized for Clinical Research Sequencing

Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Clinical Research Exome. The performance-optimized exome design was developed in collaboration with researchers from Emory University and the Children's Hospital of Philadelphia. SureSelect Human All Exon V5 was used as the core for the new design. Performance has been enhanced in disease-associated regions, providing 10 percent ...

Jul. 16, 2014

By Agilent Technologies, Inc.
Agilent Technologies Introduces SureSelectQXT Target Enrichment Kits for Same-Day Sample-to-Sequencing

Agilent Technologies Inc. (NYSE: A) today introduced the SureSelectQXT Reagent Kit, a revolutionary next-generation sequencing target enrichment solution that produces sample-to-sequencing-ready libraries in just seven hours with only 50 ng of input gDNA. Designed to meet the exacting needs of clinical researchers for a fast, easy, same-day sample-to-sequencing workflow, SureSelectQXT kits are ...

Jun. 2, 2014

By Agilent Technologies, Inc.
Agilent Technologies Announces Global Distribution Agreement with Cartagenia for CNV Analysis

Agilent Technologies Inc. (NYSE: A) today announced an agreement for global distribution of Cartagenia's cloud-based software for copy number variation (CNV) analysis. This agreement will enable Agilent to sell usage-priced annual licenses for Cartagenia's Bench Lab CNV module to small and medium-sized cytogenetic laboratories. The use-based licenses allow labs with limited budgets and little or ...

May 29, 2014

By Agilent Technologies, Inc.
Agilent Technologies Introduces New SureDirect Blood PCR Kit

Agilent Technologies Inc. (NYSE: A) today introduced the new SureDirect Blood PCR Kit for amplification of DNA directly from blood and blood derivatives, without the need for nucleic acid extraction and isolation. This kit simplifies the DNA amplification workflow and decreases turn-around time by enabling PCR (polymerase chain reaction) directly from fresh, frozen and dried blood, as well as ...

May 15, 2014

By Agilent Technologies, Inc.
Agilent Technologies, Cell Line Genetics Collaborate on High-Throughput Cell-Line Characterization Services for Regenerative Medicine, Cancer Researchers

Agilent Technologies Inc. (NYSE: A) today announced a collaboration with Cell Line Genetics, Inc., a leading provider of cell-line characterization and quality assurance services. CLG will develop high-throughput, genomic characterization workflows to confirm and monitor the integrity of cell lines for translational and regenerative medicine research. The workflows will be based upon Agilent's ...

Feb. 11, 2014

By Agilent Technologies, Inc.
NIH Study Offers Insight into Why Cancer Incidence Increases with Age

The accumulation of age-associated changes in a biochemical process that helps control genes may be responsible for some of the increased risk of cancer seen in older people, according to a National Institutes of Health study. Scientists have known for years that age is a leading risk factor for the development of many types of cancer, but why aging increases cancer risk remains unclear. ...

Feb. 3, 2014

By National Institute of Environmental Health Sciences (NIEHS)
Agilent Technologies Thought Leader Award Supports Dr. Paul Watkins, Hamner-UNC Institute for Drug Safety Sciences

Agilent Technologies Inc. (NYSE: A) today announced that Dr. Paul B. Watkins, international drug safety expert and director of the Hamner-University of North Carolina Institute for Drug Safety Sciences, has received an Agilent Thought Leader Award in recognition of his ongoing work developing integrated methods to predict drug-induced liver injury (DILI). This award continues Agilent's support ...

Jan. 21, 2014

By Agilent Technologies, Inc.
Dako Publishes Sixth Edition of Immunohistochemistry Guidebook

Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, today introduced the latest version of "The Educational Guidebook: IHC Staining Methods." Since Dako released the guidebook's fifth edition in 2009, more than 20,000 copies have been published, plus an additional 3,000 online copies downloaded each year. This globally recognized book on IHC staining methods is ...

Dec. 12, 2013

By Agilent Technologies, Inc.
Agilent Technologies Oligo Design Tool Expanded to Include Custom CGH, ChIP-on-Chip, DNA Methylation Array Capabilities

Agilent Technologies Inc. (NYSE: A) today introduced an enhanced version of SureDesign software enabling clinical researchers to design customized CGH (comparative genomic hybridization), ChIP-on-chip (chromatin immunoprecipitation), and DNA methylation microarrays for molecular cytogenomics and other applications. The new version of SureDesign replaces these microarray applications for the ...

Nov. 18, 2013

By Agilent Technologies, Inc.
Agilent Technologies Expands Catalog of SureFISH Break-Apart Probes

Agilent Technologies Inc. (NYSE: A) today introduced SureFISH ALK, ROS1 and RET break-apart translocation probes, expanding its offering of oligonucleotide-based fluorescent in situ hybridization (FISH) products. Agilent now offers more than 450 FISH probes The majority of FISH probes available on the market use BAC technology. BAC probes target repeat regions, and probe choices are limited by ...

Nov. 13, 2013

By Agilent Technologies, Inc.
Agilent Technologies Joins Forces with Baylor College of Medicine to Provide Customized CGH Microarrays for Cancer, Prenatal and Postnatal Research

Agilent Technologies Inc. (NYSE: A) has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable ...

Nov. 12, 2013

By Agilent Technologies, Inc.
Agilent Technologies names Massachusetts Eye and Ear Infirmary as Certified Service Provider for Next-Generation Sequencing and aCGH Solutions

Agilent Technologies Inc. (NYSE: A) today announced that the Massachusetts Eye and Ear Infirmary, an affiliate of Harvard Medical School, has been authorized as a Certified Service Provider of Agilent's next-generation target enrichment and microarray-based comparative genomic hybridization (aCGH) solutions. MEEI is home to the medical school's Department of Ophthalmology Ocular Genomics ...

Oct. 24, 2013

By Agilent Technologies, Inc.
Agilent Technologies SureSelect Target Enrichment Now Available for Ion Proton Next-Generation Sequencing Systems

Agilent Technologies Inc. (NYSE: A) today introduced a new SureSelect target enrichment solution that allows Ion Proton users to realize the full power of their next-generation sequencers with the industry's leading human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling researchers to achieve the ...

Oct. 22, 2013

By Agilent Technologies, Inc.

Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you

Sing-In Linkedin Button

or

First name

Last name

Email

Password

Confirm password

Company name

Website

Company description

Minimum 250 characters

Business type

Industry

Location

Market focus